Kinetics delivery

The empirical rule described above for the enantiofacial differentiation in AE of primary allylic alcohols also applies to secondary allylic alcohols. The new aspect that needs to be taken into consideration in this case is the steric hindrance arising from the presence of a substituent (R4) at the carbon bearing the hydroxy group (Figure 6.3). This substituent will interfere in the process of oxygen delivery, making the oxidation of one enantiomer much faster than the reaction of the other one. The phenomenon is so acute that in practice kinetic resolution is often achieved (Figure 6.4) [27]. 

In the process of radical polymerization a monomolecular short stop of the kinetic chain arises from the delocalization of the unpaired electron along the conjugated chain and from the competition of the developing polyconjugated system with the monomer for the delivery of rr-electrons to the nf-orbitals of a transition metal catalyst in the ionic coordination process. Such a deactivation of the active center may also be due to an interaction with the conjugated bonds of systems which have already been formed. 

Why are the oceans so depleted in these trace metals Certainly it is not for the lack of availability from rock weathering or because of constraints imposed by the solubility of any unique compound of these elements. The reason must lie in the dynamics of the system of delivery of the metals to the oceans and their subsequent behavior in an ocean that cannot be simulated by simple in vitro experiments involving homogeneous reaction kinetics. 

In summary, then, the orientation of electrophilic thallation can be controlled by an appropriate manipulation of reaction conditions. Under conditions of kinetic control, ortho substitution results when chelation of the electrophilic reagent (TTFA in the studies described above) with the directing substituent permits intramolecular delivery of the electrophile, and para substitution results when such capabilities are absent this latter result is an expression of the very large steric requirements of the bulky thallium electrophile. Under conditions of thermodynamic control, however, meta substitution is observed. 

Strobel et al. (101) reported a unique approach to delivery of anticancer agents from lactide/glycolide polymers. The concept is based on the combination of misonidazole or adriamycin-releasing devices with radiation therapy or hyperthermia. Prototype devices consisted of orthodontic wire or sutures dip-coated with drug and polymeric excipient. The device was designed to be inserted through a catheter directly into a brain tumor. In vitro release studies showed the expected first-order release kinetics on the monolithic devices. 

Haines-Butterick L, Rajagopal K, Branco M et al (2007) Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells. Proc Natl Acad Sci 104 7791-7796... 

Reduction of ketones to triphenylsilyl ethers is effected by the unique Lewis acid perfluorotriphenylborane. Mechanistic and kinetic studies have provided considerable insight into the mechanism of this reaction.186 The salient conclusion is that the hydride is delivered from a borohydride ion, not directly from the silane. Although the borane forms a Lewis acid-base complex with the ketone, its key function is in delivery of the hydride. 

GIT, is considered to be lost from the absorption site, as is metabolic clearance and sequestration in various cell types and membranes (72,14). It is clear from Scheme I that the relative rates of the various processes will define the bioavailable fraction of the dose and understanding those factors which control pulmonary absorption kinetics is obviously the key to enhancing bioavailability via the lung. In a recent book (75) the molecular dependence of lung binding and metabolism was considered alongside the parallel processes of absorption, clearance and dissolution in the lung (14). Some key features of this work will be repeated as it relates to the systemic delivery of polypeptides. 

In this work we will focus on the use of the cubic phase as a delivery system for oligopeptides - Desmopressin, Lysine Vasopressin, Somatostatin and the Renin inhibitor H214/03. The amino acid sequences of these peptides are given in Table I. The work focuses on the cubic phase as a subcutaneous or intramuscular depot for extended release of peptide drugs, and as a vehicle for peptide uptake in the Gl-tract. Several examples of how the peptide drugs interact with this lipid-water system will be given in terms of phase behaviour, peptide self-diffusion, in vitro and in vivo release kinetics, and the ability of the cubic phase to protect peptides from enzymatic degradation in vitro. Part of this work has been described elsewhere (4-6). 

---